Talmi Yoav P, Goldschmied-Reouven Anna, Bakon Mati, Barshack Iris, Wolf Michael, Horowitz Zeev, Berkowicz Miriam, Keller Nathan, Kronenberg Jona
Departments of Otolaryngology-Head and Neck Surgery, The Chaim Sheba Medical Center, Israel.
Otolaryngol Head Neck Surg. 2002 Jul;127(1):22-31. doi: 10.1067/mhn.2002.126587.
Rhino-orbito-cerebral mucormycosis (ROCM) is a devastating infection of immunocompromised hosts. We present our experience with 19 ROCM cases and attempt to define preferred diagnostic and treatment protocols.
All had tissue biopsies obtained studied by direct smear, histologic studies, and cultures. Imaging was obtained in 14 cases.
Sixteen patients presented between August and November. Six had mixed fungal infections. Seven patients had end-stage underlying disease or infection and did not undergo surgery and 4 had an indolent form of disease. Patients were treated by surgery and by amphotericin B. The overall survival was 47%.
ROCM may have seasonal incidence peaking in the fall and early winter. The therapeutic approach should be unchanged in cases of mixed fungal infections. Amphotericin B with aggressive debridement remains the mainstay of treatment. Early recognition and treatment are essential. A presentation and survival-dependent classification of ROCM are offered.
鼻眶脑毛霉菌病(ROCM)是免疫功能低下宿主的一种毁灭性感染。我们介绍了19例ROCM病例的经验,并试图确定首选的诊断和治疗方案。
所有患者均进行了组织活检,通过直接涂片、组织学研究和培养进行分析。14例患者进行了影像学检查。
16例患者在8月至11月期间就诊。6例患者合并真菌感染。7例患者患有终末期基础疾病或感染,未接受手术治疗,4例患者病情呈惰性。患者接受了手术和两性霉素B治疗。总体生存率为47%。
ROCM可能有季节性发病,在秋季和初冬达到高峰。对于混合真菌感染病例,治疗方法应保持不变。两性霉素B联合积极清创仍是主要治疗手段。早期识别和治疗至关重要。本文提出了一种基于临床表现和生存情况的ROCM分类方法。